These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30524445)

  • 1. The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development.
    Benhamou D; Labi V; Getahun A; Benchetrit E; Dowery R; Rajewsky K; Cambier JC; Melamed D
    Front Immunol; 2018; 9():2715. PubMed ID: 30524445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency.
    Benhamou D; Labi V; Novak R; Dai I; Shafir-Alon S; Weiss A; Gaujoux R; Arnold R; Shen-Orr SS; Rajewsky K; Melamed D
    Cell Rep; 2016 Jul; 16(2):419-431. PubMed ID: 27346348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.
    Serr I; Fürst RW; Ott VB; Scherm MG; Nikolaev A; Gökmen F; Kälin S; Zillmer S; Bunk M; Weigmann B; Kunschke N; Loretz B; Lehr CM; Kirchner B; Haase B; Pfaffl M; Waisman A; Willis RA; Ziegler AG; Daniel C
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6659-E6668. PubMed ID: 27791035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells.
    Essig K; Hu D; Guimaraes JC; Alterauge D; Edelmann S; Raj T; Kranich J; Behrens G; Heiseke A; Floess S; Klein J; Maiser A; Marschall S; Hrabĕ de Angelis M; Leonhardt H; Calkhoven CF; Noessner E; Brocker T; Huehn J; Krug AB; Zavolan M; Baumjohann D; Heissmeyer V
    Immunity; 2017 Dec; 47(6):1067-1082.e12. PubMed ID: 29246441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
    Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
    RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.
    Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
    World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
    Burger ML; Xue L; Sun Y; Kang C; Winoto A
    Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.
    Zhu G; Chai J; Ma L; Duan H; Zhang H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):526-31. PubMed ID: 23524257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.
    Yin J; Li X; Zhang Z; Luo X; Wang L; Liu L
    Int J Oncol; 2018 Jul; 53(1):297-306. PubMed ID: 29749435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke.
    Liu XS; Chopp M; Wang XL; Zhang L; Hozeska-Solgot A; Tang T; Kassis H; Zhang RL; Chen C; Xu J; Zhang ZG
    J Biol Chem; 2013 May; 288(18):12478-88. PubMed ID: 23511639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
    Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM
    Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
    Janas ML; Hodson D; Stamataki Z; Hill S; Welch K; Gambardella L; Trotman LC; Pandolfi PP; Vigorito E; Turner M
    J Immunol; 2008 Jan; 180(2):739-46. PubMed ID: 18178811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties.
    Günzl P; Schabbauer G
    Immunobiology; 2008; 213(9-10):759-65. PubMed ID: 18926291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
    Li M; Luo R; Yang W; Zhou Z; Li C
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.